CareDx, Inc (CDNA) has a negative trailing P/E of -40.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 62.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -2.47%, forward earnings yield 1.61%. PEG 0.43 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 60/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -1.1 | -0.01 | 2.29 | 1.10 | - |
| 2017 | -3.1 | 7.37 | -27.89 | 3.54 | - |
| 2018 | -19.2 | 0.43 | 9.34 | 11.70 | - |
| 2019 | -41.4 | 0.69 | 9.18 | 7.16 | - |
| 2020 | -180.0 | 7.80 | 12.13 | 17.52 | - |
| 2021 | -77.5 | -1.63 | 5.10 | 8.02 | - |
| 2022 | -7.9 | -0.06 | 1.41 | 1.89 | - |
| 2023 | -3.4 | -0.02 | 2.47 | 2.30 | - |
| 2024 | 21.5 | -0.17 | 2.99 | 3.39 | - |
| 2025 | -47.0 | 0.34 | 3.31 | 2.64 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-2.39 | $40.63M | $-39.47M | -97.1% |
| 2017 | $-2.38 | $48.32M | $-55.47M | -114.8% |
| 2018 | $-1.31 | $76.57M | $-46.76M | -61.1% |
| 2019 | $-0.52 | $127.07M | $-21.97M | -17.3% |
| 2020 | $-0.40 | $192.19M | $-18.71M | -9.7% |
| 2021 | $-0.59 | $296.4M | $-30.66M | -10.3% |
| 2022 | $-1.44 | $321.79M | $-76.61M | -23.8% |
| 2023 | $-3.54 | $280.32M | $-190.28M | -67.9% |
| 2024 | $0.93 | $333.79M | $52.55M | 15.7% |
| 2025 | $-0.40 | $379.81M | $-21.35M | -5.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.07 | $-0.07 – $-0.07 | $431.97M | $430.76M – $434.06M | 4 |
| 2027 | $0.28 | $0.26 – $0.30 | $480.81M | $480.48M – $481.13M | 4 |
| 2028 | $0.70 | $0.69 – $0.70 | $528.39M | $522.47M – $534.3M | 1 |
